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Purpose: To compare subfoveal choroidal thickness (SFCT) and associated clinical variables in patients with 
carotid stenosis (CS) before and six months after carotid endarterectomy (CEA). 
Methods: The prospective non-randomized Helsinki Carotid Endarterectomy Study—Brain and Eye Sub-
sTudy included seventy patients (81% male, mean age 69 years) and 40 control subjects (77% male, 68 
years), from March 2015 to December 2018. Ophthalmological examination included SFCT measured with 
enhanced depth imaging-optical coherence tomography. CS was more severe (≥70% stenosis in 92%) 
ipsilateral to the CEA than contralaterally (<50% stenosis in 74%; p<0.001). 
Results: At baseline, patients had thinner mean SFCT than control subjects in both eyes (ipsilateral, 222 vs. 
257m and contralateral, 217 vs 258 m, p≤0.005). At follow-up, SFCT did not change in ipsi- and 
contralateral eyes compared to baseline in patients (p0.68 and p0.77), or in control subjects (p0.59 and 
p0.79). Patients with coronary artery disease had thinner mean SFCT vs those without it in ipsilateral eyes 
before CEA (200 vs 233 m, p0.027). In ipsilateral eyes of patients before CEA, thinner SFCT and ocular 
signs of CS, plaque and hypoperfusion related findings combined, were associated (p0.036), and the best-
corrected visual acuity, measured in logMAR, increased with increasing SFCT (r0.25; p0.046).  
 
Conclusions: SFCT is thinner in patients with CS without association between SFCT and the grade of CS. 
Unchanged SFCT after CEA suggests, that choroidal vessels in severe CS are unable to react to increased 







The ophthalmic artery, the first branch of the internal carotid artery, is the main source of blood supply to the 
eye. Up to 70% of its blood flow goes to the choroid (Mrejen &  Spaide 2013). Ophthalmic symptoms and 
signs in patients with carotid stenosis (CS) may result from embolism to the ophthalmic artery and its 
branches from an ulcerated carotid plaque (Rubin 2006) or from hypoperfusion to the globe (Arthur et al. 
2014; Hayreh 2015). Ocular signs such as Hollenhorst plaques and other posterior segment changes in the 
retina and optic nerve as well as anterior segment changes, may precede cerebral signs of CS. Clinicians 
should therefore be familiar also with these signs, in order to prevent a stroke (Lawrence &  Oderich 2002; 
Biousse et al. 2018). Unlike these changes, the effect of reduced blood flow to the choroid caused by CS, is 
less well known, however.  
 
 Full-thickness choroidal imaging has been difficult, mainly because of blocking by the retinal pigment 
epithelium (RPE). Indocyanine green angiography and ultrasonography were conventional techniques to 
visualize the choroid. Discovery of enhanced-depth imaging spectral-domain optical coherence tomography 
(EDI-OCT) enabled more precise and detailed visualization of the choroid (Spaide et al. 2008), particularly 
choroidal thickness (CT). Repeatability in subfoveal choroidal thickness (SFCT) measurements using EDI-
OCT has been validated, “a change of >32 m in SFCT exceed interobserver variability” (Rahman et al. 
2011) and better intra-observer repeatability compared to two observers has been shown (Cho et al. 2014). 
Measuring CT and choroidal volume (CV) based on Early Treatment of Diabetic Retinopathy Study (ETDRS) 
subfields has been introduced (Cheong et al. 2018). This method also requires manual measurement of CT, 
and is so far lacking normative data and assessment of repeatability. CT measurements have served in 
clarifying the pathogenesis of several ocular disorders such as age-related macular degeneration (AMD) and 
especially central serous chorioretinopathy, polypoidal choroidal vasculopathy, and other manifestations of 
the pachychoroid (Kim et al. 2011; Dansingani et al. 2016). The population-based Beijing Eye Study 
associated visual acuity with SFCT, indicating its functional role (Wei et al. 2013), and the Gutenberg Health 
Study found that CT was associated with cardiovascular risk factors (Schuster et al. 2019).  
 
Studies have shown that in eyes affected by CS, SFCT is thinner compared to fellow eyes (Kim et al. 2015; 
Wang et al. 2017; Wang et al. 2017; Akca Bayar et al. 2019) or control subjects (Sayin et al. 2015; Kang et 
al. 2019). Three studies have found either bilaterally thinner SFCT in CS (Lareyre et al. 2018), a thicker 
SFCT when CS was >70% (Akçay et al. 2016), or choroidal thinning before retinal changes (Wang et al. 
2017). The last study suggested that SFCT may perform well in choosing the optimal schedule for carotid 
surgery. Changes in SFCT before and after carotid endarterectomy (CEA) has been the topic of four small 
series (Lareyre et al. 2018; Rabina et al. 2018; Akca Bayar et al. 2019; Krytkowska et al. 2020), again with 
partly contradictory results and only one of these with control subjects (Akca Bayar et al. 2019). 
 
In an effort to elucidate some existing controversies, we conducted a larger prospective study with healthy, 
age- and gender-matched control subjects. Our aim was: 1) to compare SFCT at baseline and six months 
after CEA and 2) to discover variables associated with SFCT by use of EDI-OCT. 
 
Patients and Methods 
Study design  
This prospective non-randomized study is part of the Helsinki Carotid Endarterectomy Study - Brain and Eye 
Sub-sTudy (HeCES-BEST) conducted in the Helsinki University Hospital, Helsinki, Finland. HeCES-BEST 
involves ophthalmologists, neurologists, neuroradiologists, vascular surgeons and neuropsychologists to 
evaluate structural and functional changes in the brain and eye at baseline and six months after CEA. The 
ethics committee of the Hospital District of Helsinki and Uusimaa approved the study. Its design complies 
with the tenets of the Declaration of Helsinki. All participants gave their written informed consent.  
 
Patients and controls 
 
From March 2015 to December 2018, 71 patients and 41 control subjects were enrolled, all Caucasians. 
One patient and one control subject were excluded, the former because of inadequate co-operation in EDI-
OCT and the latter was diagnosed with cancer. The inclusion criterion was CS 70% or more in the first 
evaluation leading to CEA. Six enrolled patients had an ipsilateral CS of <70% when assessed with CTA by 
an experienced study neuroradiologist. The exclusion criterion was recent (<6 months) cerebral infarction. 
Twelve patients (17%) had undergone CEA on the contralateral side a median of 0.6 (range, 0.2–17.2) years 
earlier. Healthy, unmedicated, age- and gender-matched control subjects, who underwent carotid 
ultrasonography to rule out CS, were enrolled from senior- and exercise clubs, and among hospital staff, 
relatives and friends.  
 
Baseline and follow-up examinations 
Both eyes of the 70 patients and 40 control subjects were examined at baseline. Twenty-nine patients (41%) 
underwent right sided and 41 (59%) patients left sided CEA. The right eye served as the control for the 
ipsilateral eye in 17 (42%) and the left eye as the control for the contralateral eye in 23 (58%) control 
subjects, the sides were randomly drawn. All patients except one were operated within two weeks of 
baseline examination; one patient needed further investigations for anemia and was operated 11 weeks after 
baseline examination. Patients were examined a median of 5.9 (range, 5.3–8.6) months after CEA. Seven 
(10%) of them were lost to follow-up: one had a postoperative cerebral infarction, two did not respond to 
invitation, and four withdrew from the study. Eight patients (12%) with bilateral CS underwent CEA of the 
contralateral side a median of 0.6 (range, 0.1–2.8) months after the first CEA, and the follow-up data from 
these patients were excluded from the analysis. All control subjects were examined twice with a comparative 
interval (median, 5.9; range, 4.8–6.9 months).  
Clinical records and interview by a research assistant were used to collect patient data (Table 1). All 
participants had blood samples collected at the baseline, which are not presented in this manuscript, except 
that the diagnosis of dyslipidemia was based on low-density lipoprotein (LDL) level >3 mmol/L in our control 
subjects. Blood pressure was measured once in the sitting position from the brachial artery using an 
automatic sphygmomanometer (Omron, Omron Healthcare, Kyoto, Japan). Mean arterial pressure (MAP) 
was calculated with the formula: MAP = Diastolic blood pressure (DBP) + 0,412 x Systolic blood pressure 
(SBP) – DBP (Papaioannou et al. 2016). Body mass index (BMI) was calculated as weight (in kg) divided by 
the square of height (in meters). SBP was similar, whereas control subjects had higher DBP and MAP and 
lower BMI compared to patients (Table 1). 
Grade of CS as analyzed with computed tomography angiography (CTA) according to the North American 
Symptomatic Carotid Endarterectomy Trial (NASCET) method (Barnett et al. 1991), is described in Table 1. 
A 1.0 mm decrease in distal luminal diameter beyond a tight stenosis was used as the cut-off for a subtle 
near-occlusion (NO-s). The near-occlusion was classified as a full collapse (NO-fs) only if the luminal 




Baseline ophthalmological findings in patients and control subjects are shown in Table 2. Best-corrected 
visual acuity (BCVA) was measured in logMAR units using ETDRS charts. Intraocular pressure (IOP) was 
measured with a rebound tonometer (Icare® TA01i Tonometer, Icare Finland, Vantaa, Finland), the mean of 
three reliable measuring cycles was used. Bio-microscopy of the anterior and posterior segment was 
assessed with emphasis on findings related to impaired circulation (Lawrence &  Oderich 2002; Mendrinos et 
al. 2010). After pupillary dilatation with tropicamide (Oftan Tropikamid® 5 mg/ml, Santen, Tampere, Finland), 
ultra-widefield images were obtained with Optos® 200 Tx (Optos, Dunfermline, United Kingdom) and 50° 
color and red-free fundus photographs centered on the macula and the nasal field, and 30° photographs 
centered on the disc were taken (FF450plus, Carl Zeiss, Jena, Germany). Ocular signs of CS are dived into 
plaque- and hypoperfusion related findings (Table 3). 
 
Optical coherence tomography  
 
Spectral-domain EDI-OCT was performed using the Heidelberg Spectralis® (version 6.3.2.0; Heidelberg 
Engineering, Heidelberg, Germany). Caffeine intake and cigarette smoking was prohibited three hours 
before examination. Standardized scans were obtained using high resolution and automatic real-time 
function, with 16 frames and 49 sections in a 20° rectangle centered on the fovea. Manual calipers were 
used to measure SFCT at the center of the fovea following a standardized protocol (Boonarpha et al. 2015). 
In short, the calipers were placed at the outer edge of the hyperreflective RPE/Bruch’s complex band and the 
choroid-sclera junction. SFCT was measured twice in different sessions. If the difference between the two 
measurements was <10 m, the mean was calculated. If the difference was ≥10 m, a third measurement 
was taken and the mean of the two nearest measurements with a difference of <10 m was used. 
Measurements outside this limit were excluded from further comparison. The percentages of acceptable 
measurements in the ipsi- and contralateral eyes of the patients were 91% and 83% at baseline and 86% 
and 87% at follow-up, and in control subjects 88%, 88%, 83%, and 80%, respectively. The mean time of the 
day at the baseline EDI-OCT examination was 11:56 a.m. ( 1:28 hours) for patients and 11:48 a.m. ( 1:54 
hours) for control subjects. The corresponding times at the follow-up were: 10:59 a.m. ( 1:31 hours) and 
11:32 a.m. ( 1:56 hours), respectively.  All examinations and measurements were performed by the same 
ophthalmologist (MA-K) masked to the operated side.  
 
Statistical analysis 
Descriptive statistics for continuous normally distributed variables are presented as means (standard 
deviations) and for non-normally distributed variables as medians (ranges), and for categorical variables as 
frequencies (percentages). To compare the variables between patient and control groups, two-sample t-test 
or Mann-Whitney U-test was used for continuous variables and chi-square or Fisher’s exact for categorical 
variables. The differences in CS and ocular signs of CS between ipsi- and contralateral eyes were examined 
with McNemar-Bowker test. Mean SFCT values between ipsi- and contralateral eyes, and between pre- and 
postoperative visits were compared using linear mixed model with random intercept for a subject to account 
for the dependency between measurements on the same subject. Restricted maximum likelihood estimation 
was used in linear mixed model to get the unbiased estimates in the presence of missing data. Two-sample 
t-test was used to test the differences in mean SFCT between patients and controls. Associations of 
categorical characteristics with preoperative SFCT were analyzed using two-sample t-test or 1-way ANOVA 
with Tukey’s adjustment for multiple comparisons. Correlations between continuous clinical characteristics 
and preoperative SFCT were calculated with Pearson or Spearman correlation coefficients. Statistical 
analyses were done using SPSS for Windows (version 26, IBM, Armonk, NY). Statistical significance was set 





Subfoveal choroidal thickness  
 
At baseline, the SFCT was within 5 m of each other in both the ipsi- vs contralateral eyes of the patients 
(222 vs 217 m, p=0.90, linear mixed model) and in control subjects (257 vs 258 m, p0.72, Fig.1). The 
SFCT was 36–41 m thinner ipsi- and contralaterally in the patients compared to the control subjects 
(p0.005 and p0.004, two-sample t-test).  
At the postoperative visit, SFCT did not change in ipsi- and contralateral eyes relative to their SFCT at 
baseline (p0.68 and p0.77, linear mixed model, Fig.1). It did not differ between the ipsi- vs contralateral 
eyes, neither in the patients (225 vs 209 m, p0.13) nor in control subjects (261 vs 244, p  0.62). The 
significant difference between the patients and control subjects in SFCT ipsi- and contralaterally was 
maintained at the postoperative visit (p0.011 and p0.007, two-sample t-test). 
Grade of CS did not influence SFCT which remained unchanged postoperatively in ipsi- and contralateral 
eyes in patients with preoperative grade of CS >70% (225 vs 222 and 216 vs 212 m, respectively; p0.54 
and 0.23, linear mixed model), including patients with NO, and also in contralateral eyes in patients with 
preoperative grade of CS <50% (218 vs 214 m, p0.32). 
 
Effect of cardiovascular disease  
At baseline, patients with coronary artery disease (CAD) vs those without CAD had a thinner SFCT in the 
ipsi- but no difference in the contralateral eyes (200 vs 224 and 202 vs 224 m, p0.027 and p=0.23, two-
sample t-test, Table 4, Fig.2). At the postoperative visit, these values were not different in the ipsi- but were 
thinner in the contralateral eyes (210 vs 232 and 185 vs 219 m, p0.25 and p0.050, respectively). 
Postoperatively, SFCT in ipsi- and contralateral eyes of patients with CAD and without CAD did not change 
relative to baseline (Fig.2).   
  
Association between preoperative SFCT and clinical characteristics  
 
We further analyzed which variables besides CAD associated with SFCT at baseline. An association was 
found between thinner SFCT and ocular signs of CS in the ipsilateral eyes (p0.036, one-way ANOVA), but 
not in the contralateral eyes (p0.30, two-sample t-test, Table 4). In line with this, we found an inverse 
correlation between SFCT and logMAR in the ipsilateral eyes (r  0.25; p0.046, Spearman rank 
correlation), but not in the contralateral eyes (r 0.03; p0.81), corresponding to increasing BCVA with 
increasing SFCT. No correlation was found in ipsilateral eyes between SFCT and spherical equivalent (r  
0.11; p  0.39, Pearson correlation), age (r  0.16; p  0.20), BMI (r  0.01; p  0.95), SBP (r   0.14; p  
0.27) nor DBP (r  0.10; p  0.43). Furthermore, gender, smoking, DM, systemic hypertension, 
dyslipidemia, amaurosis fugax, AMD, time of OCT measurement and grade of CS were unassociated with 
ipsi- or contralateral SFCT (Table 4).  
The control subjects were analyzed similar to the patients, a correlation was found between SFCT and BMI 




To our knowledge, this seems to be the largest study thus far on SFCT in patients with CS before and after 
CEA. We showed thinner SFCT both before and after CEA in both eyes despite significant difference in the 
grade of CS ipsi- and contralaterally. In all evaluations, our patients had, in fact, thinner SFCT compared to 
control subjects. An association appeared also between SFCT and patients with CAD, as thinner SFCT was 
found preoperatively in ipsilateral eyes and postoperatively in the contralateral eyes. Furthermore, an 
association appeared between thinner SFCT and ocular signs of CS, and SFCT was correlated with BCVA, 
both findings in the ipsilateral eyes of our patients. 
We confirmed thinner SFCT in ipsi- and contralateral eyes in patients with CS (Fig. 1). In our study, mild CS 
on the contralateral side occurred in 74% of patients, who nevertheless had thinner SFCT, whether this 
indicates a compromised blood flow to the choroid even in mild CS is not yet known. As already mentioned, 
one study concluded, that when choosing the optimal time for surgery in CS, measuring SFCT could prove 
useful (Wang et al. 2017). Their conclusion is challenged by our finding of thin SFCT in mild CS. Our finding 
also challenges the theory that dilation of choroidal collaterals might cause choroidal thickening in early 
stages of CS (Yeung et al. 2020). On the other hand, we confirmed an absence of correlation between the 
grade of CS and SFCT (Sayin et al. 2015; Lareyre et al. 2018). 
In concordance with recent findings (Sayin et al. 2015; Kang et al. 2019; Li et al. 2019) we found thinner  
SFCT in patients with CS compared to that of control subjects (Fig.1). The mean SFCT in large population-
based studies has ranged from 252 to 255 m (Wei et al. 2013; Schuster et al. 2019). This is in line with the 
mean SFCT in our control subjects, 244 to 261 m. On the other hand, 33% of our control subjects had thin 
SFCT (<220 m), and of these 74% had bilaterally thin SFCT, and 75% had thin SFCT at both visits. It 
seems, that bilaterally thin SFCT may exist also as a normal variation. However, age-matched control 
subjects in our study, though without medications according to study protocol, had a higher DBP (single 
measurement) compared to that of the patients, and 80% were dyslipidemic (Table 1). The fact that only the 
patients used medications, such as antiplatelet and statin therapy, that enhance the circulation and 
endothelial function, might have influenced our results. If so, one could hypothesize that this would have 
narrowed the difference between the patients and control subjects which, however, was significant both 
before and after CEA. Our patients´ medication did not change during follow-up. 
Thus far, four studies on SFCT after CEA have appeared (Lareyre et al. 2018; Rabina et al. 2018; Akca 
Bayar et al. 2019; Krytkowska et al. 2020). The Lareyre-group had 36 patients at baseline of whom 28 with 
follow-up results at 1 month and 19 at 3 months (Lareyre et al. 2018). After CEA, SFCT was increased at 1 
and 3 months in the ipsilateral eyes (211 m at baseline vs 226 m at 3 months, p<0.001) and at 3 months 
in the contralateral eyes (215 m vs 220 m, p=0.04). Thinner SFCT compared to that of the normal 
population emerged in our study as well; their mean SFCT in ipsi- and contralateral eyes was comparable to 
that of our patients both pre- (211 vs 222 m and 215 vs 217 m) and postoperatively (226 vs 225 m and 
220 vs 213 m).  The Krytkowska-group measured mean CT and CV from 38 eyes of 19 patients in 9 
ETDRS subfields at baseline, and at 2 days and 3 months after CEA. Compared to baseline, CT and CV had 
not changed at 2 days in either eye, whereas at 3 months the ipsilateral eye showed increase in total CT 
(p=0.04), including from 320 to 336 m (p=0.03, without adjusting for multiple subfield comparisons) in the 
central subfield, and overall CV (p=0.01), including from 0.25 to 0.26 mm3 (p=0.06, without adjusting for 
multiple subfield comparisons) in the central subfield. Unlike these two studies, we found no increase in 
SFCT postoperatively. It is possible that either the increase in SFCT after CEA is temporary, or the variability 
in SFCT measurements prevents detection of small changes. The Rabina-group´s study included 8 patients 
with a normal preoperative SFCT (268–277 m) and no change 6 months after CEA (Rabina et al. 2018). 
The Akca Bayar-group study, using ETDRS subfields for evaluation of CT, included 43 patients with 
moderate (50-70%) or severe (>70%) CS at baseline, requiring stenting in 22 patients and CEA in 21 
patients, and 40 control subjects (Akca Bayar et al. 2019). At baseline the subfoveal CT was thinner in 
moderate and severe CS as compared to controls (242 m vs 249 m vs 264 m, p0.03, without adjusting 
for multiple subfield comparisons), as well as in the other subfields. They concluded that only stenting in 
patients with moderate CS provided a recovery in CT, suggesting that higher grade of CS may lead to 
permanent decrease in choroidal thickness. Our findings support this theory because our patients had no 
increase in SFCT after CEA.  
A study with 34 patients with CAD and 28 age-matched control subjects found significantly thinner SFCT in 
the former, concluding that “CT could serve as potential biomarker” of CAD (Ahmad et al. 2017), and the 
same suggestion appeared in a recent review (Yeung et al. 2020). Another study showed decreased 
choroidal vessel density and blood flow in OCT angiography, associated with higher grade of stenosis of 
coronary arteries (Wang et al. 2019). Our series included 22 patients with CAD, of whom 32% had had acute 
myocardial infarction, and 64% had undergone revascularization procedure. Our patients with CAD had 
thinner SFCT than did patients without CAD in ipsilateral eyes preoperatively and in contralateral eyes 
postoperatively (Fig. 2), whether thinner SFCT in CAD patients is the result of compromised blood flow in 
choroidal vessels, prone to change also on the unoperated side, remains to be determined. In the Gutenberg 
Health Study, cardiovascular risk factors such as sex, SBP, left ventricular mass index and dyslipidemia 
were associated with SFCT, mediated by aging (Schuster et al. 2019). Association of SFCT with higher BP, 
shown in other studies of DPB and higher mean blood pressure (Wei et al. 2013), as well as with arterial 
hypertension (Lareyre et al. 2018), was absent from our series. However, our patients were normotensive, 
albeit 84% had medication for arterial hypertension (Table 1).  Neither did we find any association between 
SFCT and dyslipidemia, i.e. patients with medication for dyslipidemia. Controversy exists as to how diabetes 
affects CT (Laviers &  Zambarakji 2014), we found no association there. Healthy individuals with higher BMI 
(>25) have thinner CT than do those with lower BMI (Yilmaz et al. 2015). Accordingly we found a negative 
correlation between BMI and SFCT in our healthy control subjects, but not in the patients with CS. Studies 
with EDI-OCT have confirmed age-related decline in SFCT of 16- 54m per decade (Margolis &  Spaide 
2009; Ding et al. 2011; Wei et al. 2013). Probably due to the limited age range in our patients and control 
subjects, we found no correlation between age and SFCT (Table 1). 
In our study, midperipheral hemorrhages were the most common findings in patients with ocular signs of CS 
(Table 3). These signs were associated with thinner SFCT in the ipsilateral eyes, despite that the grade of 
CS was not associated with SFCT (Table 4). To the best of our knowledge, this seems to be the first report 
on association between SFCT and signs of CS, which could suggest that thin SFCT might play a role in the 
pathogenesis of these changes. A functional role for SFCT has been suggested, because visual acuity has 
been associated with SFCT (Wei et al. 2013). We also found better BCVA with increasing SFCT in the 
ipsilateral eye of our patients. 
Diurnal variation in SFCT has occurred, ranging from 10 to 13 m (Usui et al. 2012; Lee et al. 2014). We 
observed no association between SFCT and time of its measurement, the mean time being around noon. 
Diurnal variation should not, therefore, have influenced our results. In two studies, SFCT decreased by 8.7 
and 15 m for every diopter of myopic shift (Fujiwara et al. 2009; Wei et al. 2013). None of our participants 
had high myopia, their mean spherical equivalent was slightly on the hyperopic side with the ranges in ipsi- 
and contralateral eyes of patients and control subjects being similar (Table 2). Their spherical equivalent 
showed no correlation with SFCT.  
All our study participants were Caucasians and mostly males, hence making our findings valid accordingly. 
Limitations in our study include lack of data on axial length, anterior chamber depth, and lens thickness, all of 
which may influence SFCT measurements (Wei et al. 2013). Another limitation concerns EDI-OCT 
measurement protocol, although we used high resolution and automatic real-time function, best quality in 
images would have required 100 averaged scans in each section. To our benefit, we evaluated SFCT in 
separate sessions and used only measurements within 10 m to exclude images with indistinct choroid-
sclera junction. Most of the studies on CT have not revealed their protocol in EDI-OCT imaging, however.   
In conclusion, the bilaterally thin SFCT found in patients with CS, could be considered as yet another sign of 
CS, though bearing in mind that this finding may overlap with normal variation. Thin SFCT occured even in 
mild CS (<50%). An absence of recovery in SFCT after CEA supports the hypothesis that choroidal vessels 
may be unable to react to increased blood flow in patients with severe CS (>70%). Thin SFCT in patients 
with CAD, suggests that, in such patients, the systemic effect of atherosclerotic disease plays an additive 
role with local hemodynamic effect of CS. Furthermore, whether thin SFCT plays a role in the pathogenesis 
of ocular signs of CS, as demonstrated by midperipheral hemorrhages and other signs of ocular ischemic 
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